These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 31871024

  • 1. Tuning Subunit Vaccines with Novel TLR Triagonist Adjuvants to Generate Protective Immune Responses against Coxiella burnetii.
    Gilkes AP, Albin TJ, Manna S, Supnet M, Ruiz S, Tom J, Badten AJ, Jain A, Nakajima R, Felgner J, Davies DH, Stetkevich SA, Zlotnik A, Pearlman E, Nalca A, Felgner PL, Esser-Kahn AP, Burkhardt AM.
    J Immunol; 2020 Feb 01; 204(3):611-621. PubMed ID: 31871024
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Promiscuous Coxiella burnetii CD4 Epitope Clusters Associated With Human Recall Responses Are Candidates for a Novel T-Cell Targeted Multi-Epitope Q Fever Vaccine.
    Scholzen A, Richard G, Moise L, Baeten LA, Reeves PM, Martin WD, Brauns TA, Boyle CM, Raju Paul S, Bucala R, Bowen RA, Garritsen A, De Groot AS, Sluder AE, Poznansky MC.
    Front Immunol; 2019 Feb 01; 10():207. PubMed ID: 30828331
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The Feasibility of Using Coxiella burnetii Avirulent Nine Mile Phase II Viable Bacteria as a Live Attenuated Vaccine Against Q fever.
    Kumaresan V, Alam S, Zhang Y, Zhang G.
    Front Immunol; 2021 Feb 01; 12():754690. PubMed ID: 34795669
    [Abstract] [Full Text] [Related]

  • 7. Soluble antigens derived from Coxiella burnetii elicit protective immunity in three animal models without inducing hypersensitivity.
    Gregory AE, van Schaik EJ, Fratzke AP, Russell-Lodrigue KE, Farris CM, Samuel JE.
    Cell Rep Med; 2021 Dec 21; 2(12):100461. PubMed ID: 35028605
    [Abstract] [Full Text] [Related]

  • 8. Identification of Coxiella burnetii CD8+ T-Cell Epitopes and Delivery by Attenuated Listeria monocytogenes as a Vaccine Vector in a C57BL/6 Mouse Model.
    Xiong X, Jiao J, Gregory AE, Wang P, Bi Y, Wang X, Jiang Y, Wen B, Portnoy DA, Samuel JE, Chen C.
    J Infect Dis; 2017 May 15; 215(10):1580-1589. PubMed ID: 27703037
    [Abstract] [Full Text] [Related]

  • 9. Enhanced protection against Q fever in BALB/c mice elicited by immunization of chloroform-methanol residue of Coxiella burnetii via intratracheal inoculation.
    Feng J, Hu X, Fu M, Dai L, Yu Y, Luo W, Zhao Z, Lu Z, Du Z, Zhou D, Wen B, Jiao J, Xiong X.
    Vaccine; 2019 Sep 24; 37(41):6076-6084. PubMed ID: 31477436
    [Abstract] [Full Text] [Related]

  • 10. Chemokine Receptor 7 Is Essential for Coxiella burnetii Whole-Cell Vaccine-Induced Cellular Immunity but Dispensable for Vaccine-Mediated Protective Immunity.
    Chen C, van Schaik EJ, Gregory AE, Vigil A, Felgner PL, Hendrix LR, Faris R, Samuel JE.
    J Infect Dis; 2019 Jul 19; 220(4):624-634. PubMed ID: 30938819
    [Abstract] [Full Text] [Related]

  • 11. Coxiella burnetii: host and bacterial responses to infection.
    Waag DM.
    Vaccine; 2007 Oct 16; 25(42):7288-95. PubMed ID: 17825460
    [Abstract] [Full Text] [Related]

  • 12. Comparative efficacy of a Coxiella burnetii chloroform:methanol residue (CMR) vaccine and a licensed cellular vaccine (Q-Vax) in rodents challenged by aerosol.
    Waag DM, England MJ, Pitt ML.
    Vaccine; 1997 Nov 16; 15(16):1779-83. PubMed ID: 9364683
    [Abstract] [Full Text] [Related]

  • 13. Evaluation of a Human T Cell-Targeted Multi-Epitope Vaccine for Q Fever in Animal Models of Coxiella burnetii Immunity.
    Sluder AE, Raju Paul S, Moise L, Dold C, Richard G, Silva-Reyes L, Baeten LA, Scholzen A, Reeves PM, Pollard AJ, Garritsen A, Bowen RA, De Groot AS, Rollier C, Poznansky MC.
    Front Immunol; 2022 Nov 16; 13():901372. PubMed ID: 35651616
    [Abstract] [Full Text] [Related]

  • 14. Components of protective immunity.
    Zhang G, Zhang Y, Samuel JE.
    Adv Exp Med Biol; 2012 Nov 16; 984():91-104. PubMed ID: 22711628
    [Abstract] [Full Text] [Related]

  • 15. Eosinophils Affect Antibody Isotype Switching and May Partially Contribute to Early Vaccine-Induced Immunity against Coxiella burnetii.
    Ledbetter L, Cherla R, Chambers C, Zhang Y, Zhang G.
    Infect Immun; 2019 Nov 16; 87(11):. PubMed ID: 31427447
    [Abstract] [Full Text] [Related]

  • 16. Attenuated Coxiella burnetii phase II causes a febrile response in gamma interferon knockout and Toll-like receptor 2 knockout mice and protects against reinfection.
    Ochoa-Repáraz J, Sentissi J, Trunkle T, Riccardi C, Pascual DW.
    Infect Immun; 2007 Dec 16; 75(12):5845-58. PubMed ID: 17893129
    [Abstract] [Full Text] [Related]

  • 17. Adaptive immunity to the obligate intracellular pathogen Coxiella burnetii.
    Shannon JG, Heinzen RA.
    Immunol Res; 2009 Dec 16; 43(1-3):138-48. PubMed ID: 18813881
    [Abstract] [Full Text] [Related]

  • 18. Mechanisms of vaccine-induced protective immunity against Coxiella burnetii infection in BALB/c mice.
    Zhang G, Russell-Lodrigue KE, Andoh M, Zhang Y, Hendrix LR, Samuel JE.
    J Immunol; 2007 Dec 15; 179(12):8372-80. PubMed ID: 18056383
    [Abstract] [Full Text] [Related]

  • 19. Coxiella burnetii Whole Cell Vaccine Produces a Th1 Delayed-Type Hypersensitivity Response in a Novel Sensitized Mouse Model.
    Fratzke AP, Gregory AE, van Schaik EJ, Samuel JE.
    Front Immunol; 2021 Dec 15; 12():754712. PubMed ID: 34616410
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.